Provided by Tiger Trade Technology Pte. Ltd.

Jupiter Neurosciences

4.18
-0.7100-14.52%
Post-market: 3.13-1.0500-25.12%19:58 EDT
Volume:254.19K
Turnover:1.14M
Market Cap:5.10M
PE:-0.23
High:5.15
Open:5.15
Low:4.10
Close:4.89
52wk High:137.96
52wk Low:4.10
Shares:1.22M
Float Shares:958.24K
Volume Ratio:0.02
T/O Rate:26.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-18.5676
EPS(LYR):-18.7500
ROE:-1888.70%
ROA:-159.56%
PB:-13.94
PE(LYR):-0.22

Loading ...

Psychedelic: PharmAla enters license agreement with Jupiter Neurosciences

TIPRANKS
·
Jul 23

Jupiter Neurosciences Director Andrew Jon Cutler Files Initial Beneficial Ownership Statement

Reuters
·
Jul 23

Jupiter Neurosciences Licenses ALA-002 for U.S. Development

TIPRANKS
·
Jul 22

Jupiter Neurosciences Stock (JUNS) Jumps on a New License Deal

TIPRANKS
·
Jul 22

Jupiter Neurosciences (nasdaq: Juns) Signs Definitive Agreement for Exclusive U.S. Rights to Ala-002 in Transaction Valued at up to $100 Million

THOMSON REUTERS
·
Jul 21

Jupiter Neurosciences - Royalty of 3% of Net Sales After Third Commercialization Milestone

THOMSON REUTERS
·
Jul 21

Jupiter Neurosciences - Deal Valued at up to $100 Mln Including Milestone Payments

THOMSON REUTERS
·
Jul 21

Pharmala Licenses Exclusive US Rights to Ala-002 to Jupiter Neurosciences for up to Us$100 Million

Reuters
·
Jul 21

Pharmala Biotech - to Manufacture Gmp-grade Ala-002 for Jupiter Under Separate Supply Agreement

THOMSON REUTERS
·
Jul 21

Pharmala Biotech - Development and Regulatory Milestones up to $23.33 Mln Including $20 Mln for FDA Approval

THOMSON REUTERS
·
Jul 21

Pharmala Biotech Executes Definitive License Agreement Granting Jupiter Neurosciences Exclusive U.S. Rights to Ala-002

THOMSON REUTERS
·
Jul 21

Pharmala Biotech - Upfront Payment of $3.33 Mln: $1.50 Mln Cash, $1.83 Mln in Jupiter Stock

THOMSON REUTERS
·
Jul 21

Pharmala Biotech - Deal Valued up to $100 Mln Including $3.33 Mln Upfront and Milestones Plus Royalties

THOMSON REUTERS
·
Jul 21

Pharmala Biotech - to Receive 3% Royalty on U.S. Net Sales After Third Milestone

THOMSON REUTERS
·
Jul 21

Jupiter Neurosciences Names Former White House Economic Adviser Tomas Philipson to Board

Reuters
·
Jul 07

Jupiter Neurosciences Strengthens Board with Appointment of DR. Tomas J. Philipson

THOMSON REUTERS
·
Jul 07

Jupiter Neurosciences Appoints Tomas J. Philipson to Board

Reuters
·
Jul 01

Top Premarket Decliners

MT Newswires Live
·
Jun 29

Jupiter Neurosciences - Files for Resale of up to 16 Mln Shares by Selling Stockholder - SEC Filing

THOMSON REUTERS
·
Jun 27

Jupiter Neurosciences Announces Board Member Resignation and Vacancy

TIPRANKS
·
Jun 22